Cargando…
Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV
BACKGROUND: Triple infection (TI) with HIV-1, HCV, and HBV (TI) is highly prevalent in intravenous drug users (IDUs). These TI patients have a faster progression to AIDS, and even after antiretroviral therapy (ART) the prognosis of their disease is poor. The use of microRNA (miRNA) to silence genes...
Autores principales: | Khokhar, Ambreen, Noorali, Samina, Sheraz, Muhammad, Mahalingham, Kuha, Pace, Donald G., Khanani, Mohammad R., Bagasra, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535683/ https://www.ncbi.nlm.nih.gov/pubmed/23289041 http://dx.doi.org/10.3402/ljm.v7i0.19774 |
Ejemplares similares
-
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022) -
SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020) -
Cytomegalovirus Infection following Kidney Transplantation: a Multicenter Study of 3065 Cases
por: Einollahi, B.
Publicado: (2012) -
HBV and HCV Therapy
por: Lampertico, Pietro, et al.
Publicado: (2009) -
Resolved HBV behavior during the treatment of chronic HCV infection with direct-acting antivirals
por: Mohamed, Salem Y., et al.
Publicado: (2019)